Tango Therapeutics Inc (NAS:TNGX)
$ 9.982 0.31 (3.2%) Market Cap: 1.07 Bil Enterprise Value: 752.88 Mil PE Ratio: 0 PB Ratio: 4.18 GF Score: 52/100

Tango Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 15, 2022 / 06:20PM GMT
Release Date Price: $4.09 (+3.28%)
Chris Shibutani
Goldman Sachs - Analyst

Welcome, everybody, to our Wednesday presentations here at the Goldman Sachs conference. My name is Chris Shibutani. I'm a member of the research team covering biotechnology and pharmaceutical stocks. And my team is especially pleased to be able to have one of the exciting new stories, Tango Therapeutics, a newly public company during the past year.

And we have joining us onstage Barbara Weber on the webcast, and she has her very strong team as well. Daniella Beckman is hiding, but she is certainly here. And I know that investors at the event will have the opportunity to interact with her as well.

Questions & Answers

Chris Shibutani
Goldman Sachs - Analyst

Perhaps to get us underway, Barbara, we would love to get starters about you actually because I think it's very helpful and important for people to understand who they're hearing from and the journey that took you to lead this organization, because I think you have this blend of scientific as well as experience in the broader pharmaceutical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot